(Q30931175)

27 June 2017

title

Serum biomarkers of hepatitis B virus infected liver inflammation: a proteomic study (English)

1 reference

27 June 2017

Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study (English)

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

2 January 2024

0 references

0 references

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

2 January 2024

1

Qing-Yu He

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12748946

2 January 2024

author name string

Yuan Zhou

3

1 reference

27 June 2017

Siu-Tsan Yuen

4

1 reference

27 June 2017

Hsiang-Fu Kung

6

1 reference

27 June 2017

Jen-Fu Chiu

7

1 reference

27 June 2017

George K. K. Lau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12748946

2 January 2024

Marie C. Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12748946

2 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12748946

2 January 2024

publication date

1 May 2003

1 reference

full work available at URL

27 June 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpmic.200300394

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

https://onlinelibrary.wiley.com/doi/full/10.1002/pmic.200300394

2 January 2024

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

2 January 2024

1 reference

27 June 2017

volume

3

1 reference

27 June 2017

issue

5

1 reference

27 June 2017

page(s)

666-674

1 reference

Changing scene in hepatitis B serology interpretation

27 June 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Hepatitis B infection in China

2 January 2024

6

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Journal of Proteome Research

2 January 2024

8

1

15

Hunt D. F.

2002

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Identification of novel targets for cancer therapy using expression proteomics

2 January 2024

10

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.

2 January 2024

12

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

2 January 2024

13

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Apolipoprotein AI isoforms in serum determined by isoelectric focusing and immunoblotting

2 January 2024

15

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

2 January 2024

16

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

2 January 2024

17

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Acute phase proteins in chronic and malignant liver diseases

2 January 2024

19

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

2 January 2024

21

21

65

Pateva R.

1982

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Haptoglobin- and group-specific component-phenotypes in healthy carriers of antibodies to hepatitis B surface antigen (author's transl)

2 January 2024

22

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

2 January 2024

Terapevticheskii arkhiv

23

72

18

Volchkova E. V.

2000

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Serum apoproteins A and B and the lecithin: cholesterol acyl transferase activities in liver cirrhosis and hepatic coma patients

2 January 2024

24

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis

2 January 2024

25

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Low lipoprotein (a) levels during acute viral hepatitis.

2 January 2024

26

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Lipid parameters in childhood cirrhosis and chronic liver disease

2 January 2024

27

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Transcriptional and posttranscriptional regulation of apolipoprotein E, A-I, and A-II gene expression in normal rat liver and during several pathophysiologic states

2 January 2024

28

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Decreased proapolipoprotein A-I processing in liver disease: evidence for hepatic participation in proapolipoprotein A-I conversion

2 January 2024

29

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

New alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis

2 January 2024

30

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

The role of apolipoprotein A-IV in the regulation of food intake

2 January 2024

31

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers

2 January 2024

32

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice

2 January 2024

34

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Protection against atherogenesis in mice mediated by human apolipoprotein A-IV

2 January 2024

35

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid

2 January 2024

36

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Human apolipoprotein A-IV reduces gastric acid secretion and diminishes ulcer formation in transgenic mice

2 January 2024

37

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis

2 January 2024

38

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Alterations in plasma levels of apolipoprotein A-IV in various clinical entities.

2 January 2024

39

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Reduction of intestinal apo A-IV mRNA levels in the cirrhotic rat

2 January 2024

40

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Carcinogenesis of primary liver malignancies

2 January 2024

44

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Rapid analysis of alpha1-antitrypsin PiZ genotype by a real-time PCR approach

2 January 2024

46

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency

2 January 2024

47

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Proteolytic inactivation of alpha 1-proteinase inhibitor in vivo: detection, characterization and quantitation of the main fragment excreted in the urine of leukemia patients

2 January 2024

49

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

2 January 2024

DNA topoisomerases

51

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer

2 January 2024

54

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

DNA topoisomerase IIalpha and -beta expression in human ovarian cancer

2 January 2024

56

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

Topoisomerase II-mediated alterations of K562 drug resistant sublines.

2 January 2024

57

1 reference

https://api.crossref.org/works/10.1002/PMIC.200300394

2 January 2024

Identifiers

1 reference

27 June 2017

1 reference